101 |
Beyond IVUS: OCT, NIRS, and Beyond |
Joon-Won Kang |
Dec. 08. 14 |
100 |
Case 2: How to Do Stent Sizing and Optimization by OCT? |
Takashi Kubo |
Dec. 08. 14 |
99 |
OCT Is a Novel Tool! |
Fernado Alfonso |
Dec. 08. 14 |
98 |
Vulnerable Plaque Detection: Between Biological and Morphological(OCT) Approaches |
Takashi Akasaka |
Dec. 08. 14 |
97 |
Mechanisms and Determinants of Plaque Progression, Regression and Rupture |
Gaku Nakazawa |
Dec. 08. 14 |
96 |
3D OCT: Will It Change CathLab's Landscape? |
Takashi Akasaka |
May. 09. 14 |
95 |
Beyond IVUS: OCT, NIRS, and Beyond |
Akiko Maehara |
May. 09. 14 |
94 |
Next Generation, 3D-OCT: How Beneficial in Practice? |
Evelyn Regar |
May. 08. 14 |
93 |
Current OCT: Excellent, but Still Needs to Be More Improved |
Ik-Kyung Jang |
May. 08. 14 |
92 |
IVUS Guided vs. OCT Guided in Current PCI Practice |
Takashi Kubo |
May. 07. 14 |